PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas
,The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas,Anti-PD-L1 hIgG1 (N298A) | Atezolizumab Biosimilar Antibody